The Latest Cardiac and Vascular News
March 4, 2019- Minnesota, United States and Melbourne, Australia – Osprey Medical (ASX: OSP) is pleased to announce the appointment of Mr Jim Surek as Vice President, Sales effective from March 1st. Mr Surek brings a wealth of experience and expertise to Osprey. He has over 25 years of senior […]
WAYNE, Pa.–(BUSINESS WIRE)–Vesper Medical, Inc., a private medical device company developing innovative venous stent solutions for peripheral vascular disease, today announced the appointment of Mark J. Garcia, MD, FSIR, FACR as its Chief Medical Officer. “Dr. Garcia has brought a wealth of clinical experience treating deep venous disease to our Board […]
KFAR-SABA, ISRAEL & ALISO VIEJO, Calif.–(BUSINESS WIRE)–CathWorks announced that Mike Feher has joined CathWorks as Vice President of Finance and Chief Financial Officer. His appointment coincides with US commercialization of the CathWorks FFRangio™ System. Mr. Feher will initially focus on the development of financial and operational capabilities, as well as creating […]
ST. LOUIS, March 04, 2019 (GLOBE NEWSWIRE) — Stereotaxis, Inc. (OTCQX: STXS), the global leader in innovative robotic technologies for the treatment of cardiac arrhythmias, today announced that it will release financial results for its 2018 fourth quarter and full year ended December 31, 2018 on Tuesday, March 12, 2019 […]
EDEN PRAIRIE, Minn., March 01, 2019 (GLOBE NEWSWIRE) — CHF Solutions, Inc. (NASDAQ: CHFS), today announced that effective February 25, 2019, the independent directors approved five equity awards under CHF Solution’s New-Hire Equity Incentive Plan, as material inducements to five individuals entering into employment with the Company. The equity awards […]
MASON, Ohio–(BUSINESS WIRE)–AtriCure, Inc. (Nasdaq: ATRC), a leading innovator in treatments for atrial fibrillation (Afib) and related conditions, today announced fourth quarter and full year 2018 financial results. “We are pleased with our fourth quarter performance, capping a year of strong, consistent revenue growth,” said Mike Carrel, President and Chief Executive […]
MONTREAL–(BUSINESS WIRE)–Christian Weber, PhD, MD, Chair of Preventative Vascular Medicine and Director of theInstitute for Cardiovascular Prevention at Ludwig‐Maximilians University (LMU) Munich, Germany, joins the Clinical Advisory Board (CAB) of Mperia Therapeutics Inc. “Dr Weber is that rarity: an eminent practicing cardio-vascular clinician who also has unparalleled research experience and has published key papers […]
MALVERN, Pa., Feb. 28, 2019 (GLOBE NEWSWIRE) — BioTelemetry, Inc. (NASDAQ:BEAT), the leading remote medical technology company focused on the delivery of health information to improve quality of life and reduce cost of care, announced today the election of Laura Dietch and Tiffany Olson to BioTelemetry’s Board of Directors. Ms. […]
REDWOOD CITY, Calif., Feb. 28, 2019 (GLOBE NEWSWIRE) — Avinger, Inc. (Nasdaq: AVGR), a commercial-stage medical device company marketing the first and only intravascular image-guided, catheter-based system for diagnosis and treatment of patients with Peripheral Artery Disease (PAD), today announced that it will release its financial results for the fourth […]
SOUTH SAN FRANCISCO, Calif., Feb. 28, 2019 (GLOBE NEWSWIRE) — MyoKardia, Inc. (Nasdaq: MYOK), a clinical-stage biopharmaceutical company pioneering a precision medicine approach for the treatment of serious cardiovascular diseases, today reported financial results for the fourth quarter and full year ended December 31, 2018. “2018 was MyoKardia’s most significant […]
